Stevens Institute of Technology will offer two offsite evening graduate courses in pharmaceutical engineering this fall, at the North Branch, N.J., campus of Raritan Valley Community College (RVCC). The courses are designed for career professionals who wish to obtain a graduate certificate in pharmaceutical manufacturing practices. Another two courses in the graduate certificate will be offered in spring 2003. The current course offerings represent a first-time collaboration between Stevens and RVCC.
For further information on the specifics of time, place and registration, please contact Beth Austin DeFares, Advisor for Corporate Outreach at Stevens, at 201-216-5362.
The course offering titled Introduction to Pharmaceutical Manufacturing will cover a range of topics including quality assurance and regulatory issues in pharmaceutical manufacturing. It will provide an overview of chemical and biotech process technology and equipment; dosage forms and finishing systems; facility engineering; and health, safety, and environment concepts. A regulatory and legal overview will discuss ensuring that methods, facilities, and controls used for the manufacture, processing, and packing, or holding of drug products meet requirements for safety, effectiveness, identity, strength, quality, and purity.
The second graduate course, titled Good Manufacturing Practices in Pharmaceutical Facilities Design, will cover Current Good Manufacturing Practice compliance issues in pharmaceutical and biopharmaceutical facility design. It will also consider issues related to process flow, material flow, and people flow.
Explored as well will be A&E disciplines, including architecture, process, piping, mechanical, industrial, HVAC, automation, electrical, and computer. Issues such as bio-safety levels, developing effective written procedures, and process assurance will be covered. The course will also consider how to defend products against contamination.
"The graduate courses in pharmaceutical engineering are yet more evidence of Stevens' outreach to those seeking to add to their professional expertise," said Dr. Bernard Gallois, dean of Stevens' Schaefer School of Engineering. "We look forward to a continued, rewarding collaboration with our colleagues at the RVCC."
"We welcome Stevens to our University Center," said Dr. G. Jeremiah Ryan, president of RVCC. "The graduate courses in pharmaceutical engineering will further RVCC's goals of maximizing educational opportunities for our students and assisting area businesses in meeting the need for a highly skilled workforce," he continued.
The collaboration with Stevens is part of RVCC's University Center, which encompasses dual admission and degree completion agreements with area higher education institutions, enabling students to earn credits toward both undergraduate and graduate degrees at the North Branch campus.
Founded in 1870, Stevens Institute of Technology is one of the leading technological universities in the world dedicated to learning and research. Through its broad-based curricula, nurturing of creative inventiveness, and cross disciplinary research, the Institute is at the forefront of global challenges in engineering, science, and technology management. Partnerships and collaboration between, and among, business, industry, government and other universities contribute to the enriched environment of the Institute. A new model for technology commercialization in academe, known as Technogenesis®, involves external partners in launching business enterprises to create broad opportunities and shared value.
Stevens offers baccalaureates, master’s and doctoral degrees in engineering, science, computer science and management, in addition to a baccalaureate degree in the humanities and liberal arts, and in business and technology. The university has a total enrollment of 2,150 undergraduate and 3,500 graduate students, with about 250 full-time faculty. Stevens’ graduate programs have attracted international participation from China, India, Southeast Asia, Europe and Latin America. Additional information may be obtained from its web page at www.stevens.edu.
For the latest news about Stevens, please visit StevensNewsService.com.